IN
Integrated BioPharma, Inc.
INBP · OTC
$0.18 +1.11% (+$0.00)
1M -3.23%
Market Cap $5.25M
P/E Ratio -
Div. Yield -
ROE 8.32%
Bulios Fair Price
$0.24
31.9% upside
Trenutna cena
$0.18
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica INBP trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
69 /100
Cheap P/FCF 1.86x
P/B 0.28x
EV/EBITDA 49.45x
Growth
9 /100
Declining Book val. growth 3.03%
FCF growth 19.59%
EPS growth 40.02%
Profitability
13 /100
Weak FCF margin 5.85%
Op. margin 2.58%
Gross margin 4.64%
Quality
15 /100
Poor Asset turnover 1.81x
ROA 6.20%
ROIC 8.26%
Debt
100 /100
Low Current ratio 3.25x
Net debt/EBITDA -44.29x
Debt/Equity 0.18x
Stability
47 /100
Moderate Profitable years 2
EPS volatility 373.01%
Beta 0.40x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o INBP
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Riva Sheppard
Employees
153
Headquarters
Hillside